Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice.
Rom O, Xu G, Guo Y, Zhu Y, Wang H, Zhang J, Fan Y, Liang W, Lu H, Liu Y, Aviram M, Liu Z, Kim S, Liu W, Wang X, Chen YE, Villacorta L.
Rom O, et al. Among authors: aviram m.
EBioMedicine. 2019 Mar;41:62-72. doi: 10.1016/j.ebiom.2019.02.019. Epub 2019 Feb 13.
EBioMedicine. 2019.
PMID: 30772307
Free PMC article.
Thus, the potential benefit of in vivo administration of OA-NO(2) to treat advanced NAFLD was tested herein in a model of long-term NASH diet-induced liver damage. METHODS: Non-invasive imaging (e.g. photoacustic-ultrasound (PA-US)) was pursued to establish advanced experi …
Thus, the potential benefit of in vivo administration of OA-NO(2) to treat advanced NAFLD was tested herein in a model of long-term N …